早期活动性类风湿关节炎患者初始住院与门诊治疗结局比较:CORRA试验的事后分析
基于CORRA随机试验的事后分析,比较280例门诊与95例住院早期活动性类风湿关节炎患者12周结局;住院患者第8周和第12周临床疾病活动指数缓解率更高(第8周24.7% vs 14.9%,第12周30.5% vs 17.3%),多变量模型OR分别为2.43和2.91。
要点
- 住院患者第8周临床疾病活动指数缓解率24.7% vs 门诊14.9%,第12周30.5% vs 17.3%。
- 多变量模型显示住院与第8周缓解相关OR=2.43(95%CI 1.06-5.55;p=0.035)。
- 多变量模型显示住院与第12周缓解相关OR=2.91(95%CI 1.37-6.14;p=0.005)。
核心结论
- 在早期活动性类风湿关节炎中,初始住院治疗与第8周和第12周更高的临床疾病活动指数缓解率相关,可能归因于初始更密集的医院照护。
研究设计与样本
- CORRA随机试验的事后分析,该试验研究两种12周糖皮质激素桥接策略(高或低剂量对比安慰剂)并延长9个月,本分析按初始住院或门诊治疗比较12周结局。
主要发现
- 共分析280例门诊和95例住院患者的数据;住院患者更多为男性、心血管合并症更少,但基线临床疾病活动指数评分更高、抑郁症状更多。
- 第8周临床疾病活动指数缓解率住院患者24.7% vs 门诊患者14.9%,第12周住院患者30.5% vs 门诊患者17.3%。
- 多变量模型中,住院与第8周缓解相关OR=2.43(95%CI 1.06-5.55;p=0.035),与第12周缓解相关OR=2.91(95%CI 1.37-6.14;p=0.005)。
局限性
- 本分析为事后分析,初始治疗策略无随机化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treatment strategies of patients with active rheumatoid arthritis (RA) vary within and between countries. While most patients in Germany are treated on an outpatient basis, some are hospitalised (inpatients). In the recently published randomised CORRA (CORRA, CORticoid bridging in Rheumatoid Arthritis) trial, we studied two 12 week glucocorticoid (GC) bridging strategies in patients with early RA comparing high or low GC doses with placebo, followed by an extension phase of 9 months. Here, in this posthoc analysis, we compared 12 week outcomes of patients according to their initial treatment as inpatients or outpatients. METHODS: Inpatients initially spent 2-5 days (short-term) or 14 days (long-term) in one tertiary rheumatology hospital. Outpatients were mostly treated in rheumatology practices. There was no randomisation regarding the initial treatment strategy. The main endpoint of this posthoc analysis was Clinical Disease Activity Index (CDAI) remission at weeks 4, 8 and 12. RESULTS: Data of 280 outpatients and 95 inpatients could be analysed. Inpatients were more often male, had less cardiovascular comorbidity, but higher baseline CDAI scores and more symptoms of depression compared with outpatients. At weeks 8 and 12, CDAI remission was more frequently observed in inpatients (week 8: 24.7 vs 14.9%; week 12: 30.5 vs 17.3%). These results were confirmed in a multivariable model: OR=2.43 (1.06; 5.55); p=0.035, and OR=2.91 (1.37; 6.14); p=0.005, respectively. CONCLUSION: In early active RA, initial inpatient treatment was associated with higher CDAI remission rates at weeks 8 and 12. This may be due to the initially more intense hospital care.
引用
- Mai A, Krause D, Klaassen-Mielke R, et al. Comparing outcomes of patients with early active rheumatoid arthritis initially treated on an inpatient or outpatient basis: a posthoc analysis of the CORRA trial. RMD Open. 2024. PMID: 39438083. doi:10.1136/rmdopen-2024-004430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。